We are live on ! Find out more
TSW

Thompson Siegel & Walmsley Portfolio holdings

AUM $5.7B
1-Year Est. Return 6.69%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$5.95B
AUM Growth
-$480M
Cap. Flow
-$535M
Cap. Flow %
-8.99%
Top 10 Hldgs %
17.62%
Holding
414
New
33
Increased
111
Reduced
196
Closed
29

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$64.5M
2
NFG icon
National Fuel Gas
NFG
+$51.8M
3
RYAAY icon
Ryanair
RYAAY
+$43.1M
4
LBTYK icon
Liberty Global Class C
LBTYK
+$34.8M
5
LH icon
Labcorp
LH
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 14.96%
2 Industrials 13.89%
3 Consumer Staples 10.87%
4 Technology 10.61%
5 Financials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALO icon
126
Talos Energy
TALO
$2.48B
$10.6M 0.18%
1,088,312
-258,366
-19% -$2.45M
GLNG icon
127
Golar LNG
GLNG
$5B
$9.98M 0.17%
262,617
+4,782
+2% +$187K
BATRK icon
128
Atlanta Braves Holdings Series B
BATRK
$3.27B
$9.89M 0.17%
247,312
-16,006
-6% -$624K
SO icon
129
Southern Company
SO
$107B
$9.88M 0.17%
107,449
FUN icon
130
Cedar Fair
FUN
$1.8B
$9.82M 0.17%
275,436
+68,103
+33% +$2.9M
TDW icon
131
Tidewater
TDW
$3.55B
$9.63M 0.16%
227,746
+8,563
+4% +$426K
HES
132
DELISTED
Hess
HES
$9.39M 0.16%
58,770
+2,817
+5% +$414K
ATKR icon
133
Atkore
ATKR
$3.16B
$9.15M 0.15%
152,475
+89,191
+141% +$6.37M
GILD icon
134
Gilead Sciences
GILD
$163B
$9.03M 0.15%
80,591
-30,700
-28% -$3.17M
CVS icon
135
CVS Health
CVS
$134B
$8.81M 0.15%
129,973
+3,467
+3% +$207K
SDRL icon
136
Seadrill
SDRL
$2.66B
$8.76M 0.15%
350,234
+94,901
+37% +$2.94M
WMT icon
137
Walmart Inc
WMT
$881B
$8.73M 0.15%
99,503
-16,857
-14% -$1.58M
PTEN icon
138
Patterson-UTI
PTEN
$3.9B
$8.67M 0.15%
1,054,472
+324,583
+44% +$2.72M
AXP icon
139
American Express
AXP
$233B
$8.65M 0.15%
32,150
-2,505
-7% -$740K
PLYM
140
DELISTED
Plymouth Industrial REIT
PLYM
$8.6M 0.14%
527,338
+109,181
+26% +$1.84M
BPOP icon
141
Popular Inc
BPOP
$11.1B
$8.42M 0.14%
91,143
-18,518
-17% -$1.8M
PFE icon
142
Pfizer
PFE
$143B
$8.28M 0.14%
326,722
-18,318
-5% -$479K
MAT icon
143
Mattel
MAT
$4.32B
$7.94M 0.13%
408,754
-128,933
-24% -$2.56M
BBY icon
144
Best Buy
BBY
$18B
$7.92M 0.13%
107,600
EQIX icon
145
Equinix
EQIX
$102B
$7.89M 0.13%
9,682
-2,888
-23% -$2.6M
GNTX icon
146
Gentex
GNTX
$4.99B
$7.83M 0.13%
+336,272
New +$8.6M
AIV
147
Aimco
AIV
$387M
$7.74M 0.13%
879,227
-17,873
-2% -$159K
GEO icon
148
The GEO Group
GEO
$4.19B
$7.66M 0.13%
262,162
-70,993
-21% -$2.04M
TJX icon
149
TJX Companies
TJX
$174B
$7.52M 0.13%
61,774
+153
+0.2% +$18.6K
BV icon
150
BrightView Holdings
BV
$1.26B
$7.37M 0.12%
573,858
+215,422
+60% +$3.08M

Similar funds

Thompson Siegel & Walmsley's Q1 2025 Portfolio in Review

As of Q1 2025, Thompson Siegel & Walmsley held 414 positions worth $5.95B, down 7.5% from $6.43B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Thompson Siegel & Walmsley withdrew a net $535M in Q1 2025, closing 29 positions and reducing 196 holdings. Its most notable exit was Ryanair, an estimated $43.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Thompson Siegel & Walmsley opened a new position in Biogen worth $35.2M.

  • Thompson Siegel & Walmsley's largest Q1 2025 buy was Biogen: 257,456 shares worth $35.2M.
  • Thompson Siegel & Walmsley added most to Amentum Holdings in Q1 2025, an estimated $28.1M increase.
  • Thompson Siegel & Walmsley's biggest Q1 2025 reduction was iShares MSCI EAFE ETF, cutting an estimated $64.5M.
  • Thompson Siegel & Walmsley fully exited Ryanair in Q1 2025, selling an estimated $43.1M.
  • Thompson Siegel & Walmsley's ten largest holdings make up 18% of its $5.95B portfolio in Q1 2025.
  • Thompson Siegel & Walmsley opened 33 new positions and closed 29 in Q1 2025.
  • Thompson Siegel & Walmsley's portfolio value fell 7.5% quarter-over-quarter to $5.95B.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2025, filed 9 May 2025.